A clinical trial that examined the use of anti-viral medicine Sotrovimab in the treatment of mild to moderate COVID-19 cases among high-risk patients in the United Arab Emirates found that 97 percent of its recipients fully recovered from the infection within 14 days, Emirates News Agency WAM reported on Sunday.
Fifty percent of the patients selected for the trial were aged 50 and above. Almost all recipients of the Sotrovimab drug had multiple health conditions, including diabetes, cardiovascular disease, cancer and obesity, WAM reported.
The monoclonal antibody treatment also resulted in 100 percent prevention of death among recipients and 99 percent reduction in emergency hospitalization.
The UAE Ministry of Health, in collaboration with Abu Dhabi’s Department of Health (DoH) and Dubai Health Authority (DHA), examined the efficacy of the medicine as a treatment against COVID-19 in high-risk patients - including children aged 12 and above and pregnant women – by administering it to 6,175 patients in Abu Dhabi.
The UAE Ministry of Health and Prevention, in collaboration with Department of Health - Abu Dhabi and Dubai Health Authority, has announced the effectiveness of #Covid_19 medicine Sotrovimab in treating mild to moderate cases among high risk-patients. pic.twitter.com/DU1bBqK050— مكتب أبوظبي الإعلامي (@admediaoffice) July 17, 2021
The UAE became one of the first countries in the world to receive a shipment of Sotrovimab in mid-June this year, following its approval by the country’s health ministry and an agreement between Abu Dhabi’s Department of health, leading purchasing organization Rafed, the drug’s manufacturer GlaxoSmithKline (GSK) and Etihad Cargo.
Bahrain’s health ministry approves emergency use of COVID-19 medication SotrovimabBahrain’s Ministry of Health has approved the emergency use of the COVID-19 medication Sotrovimab, according to a statement issued on Thursday.For ... Coronavirus
UAE approves GSK’s Sotrovimab COVID-19 drug for emergency useThe UAE’s Ministry of Health announced granting the emergency use of a new effective drug for COVID-19, Sotrovimab-VIR-7831, making the UAE the first ... Coronavirus
Kuwait approves Sotrovimab treatment for COVID-19: State mediaKuwait has approved GSK and Vir Biotechnology’s Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.Read the latest ... Coronavirus
UAE’s Abu Dhabi receives first shipment of COVID-19 medication SotrovimabUAE’s Abu Dhabi received its first shipment of the coronavirus Sotrovimab medication, becoming the first city globally to receive it, the media office ... Coronavirus